Skip to content

A Single Centre study to evaluate the efficacy of Gulaab khaas kajal

A SINGLE CENTRE, THREE ARM, PARALLEL GROUP STUDY TO EVALUATE OPHTHALMOLOGICAL SAFETY OF UNDER EYE SKIN CARE FORMULATIONS (GULAAB KHAAS KAJAL) IN HEALTHY VOLUNTEERS.

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029458
Enrollment
10
Registered
2020-12-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Gulaab Khaas Kajal: The total duration of study is 3 days following the first application of the cosmetic product (Gulaab Khaas Kajal). The subjects will be provided with 3 variants of

Sponsors

Mountain Valley Springs India Pvt Ltd India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy subjects (no infectious and evaluative pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory check-up) Indian female subjects. Between 18 to 40 years of age, with normal eye condition. Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarâ?¦.) Written informed consent signed by the subject or legally acceptable representative(s) in line with applicable regulation of country.

Exclusion criteria

Exclusion criteria: Having refused to give her assent by not signing the consent form Taking part in another study liable to interfere with this study Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products Having cutaneous hypersensitivity. Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted)

Design outcomes

Primary

MeasureTime frame
Subject assessment will be done at the end of the studyTimepoint: Subject assessment will be done at the end of the study

Secondary

MeasureTime frame
Safety Evaluation by the Investigator will be done at the end of studyTimepoint: Subject assessment will be done at the end of the study

Countries

India

Contacts

Public ContactDr Shailly Gupta

Dr Gupta Clinic

drsgupta77@yahoo.com9811837215

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026